Clinical trial
AML Treatment in Untreated Adult Patients
NCT00449319 · Gruppo Italiano Malattie EMatologiche dell'Adulto, Other · Unknown status
Key facts
| NCT number | NCT00449319 |
|---|---|
| Title | AML Treatment in Untreated Adult Patients |
| Official title | AML Treatment in Untreated Adult Patients According to EORTC-GIMEMA Protocols AML8 and AML10 |
| Acronym | LAM99P |
| Lead sponsor | Gruppo Italiano Malattie EMatologiche dell'Adulto, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Leukemia, Myelocytic, Acute |
| Intervention type | Drug, Procedure |
| Interventions | Identification of appropriate therapies according to risks factors, Daunorubicine, Transplant |
| Start date | Nov 1, 1998 |
| Primary completion | Jun 1, 2018 |
| Completion | Jul 1, 2018 |
| First posted | Mar 20, 2007 |
| Last update posted | Nov 17, 2017 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: